Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation

被引:32
|
作者
Patel, P. [1 ,2 ,3 ]
Gupta, P. K. C. [1 ,2 ,3 ]
White, C. M. J. [2 ,4 ]
Stanley, A. G. [4 ]
Williams, B. [5 ,6 ]
Tomaszewski, M. [2 ,3 ,4 ]
机构
[1] Univ Hosp Leicester NHS Trust, Dept Metab Med & Chem Pathol, Leicester, Leics, England
[2] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
[3] Glenfield Gen Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England
[4] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
[5] UCL, Inst Cardiovasc Sci, London, England
[6] Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England
基金
英国医学研究理事会;
关键词
TREATMENT-RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; ADHERENCE; URINE; ELIGIBILITY; MEDICATION; TRIAL; DRUGS;
D O I
10.1038/jhh.2015.103
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Renal denervation is a potential therapeutic option for resistant hypertension. A thorough clinical assessment to exclude reversible/spurious causes of resistance to antihypertensive therapy is required prior to this procedure. The extent to which non-adherence to antihypertensive treatment contributes to apparent resistance to antihypertensive therapy in patients considered for renal denervation is not known. Patients (n = 34) referred for renal denervation entered the evaluation pathway that included screening for adherence to antihypertensive treatment by high-performance liquid chromatography-tandem mass spectrometry-based urine analysis. Biochemical non-adherence to antihypertensive treatment was the most common cause of non-eligibility for renal denervation-23.5% of patients were either partially or completely non-adherent to prescribed antihypertensive treatment. About 5.9% of those referred for renal denervation had admitted non-adherence prior to performing the screening test. Suboptimal pharmacological treatment of hypertension and 'white-coat effect' accounted for apparently resistant hypertension in a further 17.7 and 5.9% of patients, respectively. Taken together, these three causes of pseudo-resistant hypertension accounted for 52.9% of patients referred for renal denervation. Only 14.7% of referred patients were ultimately deemed eligible for renal denervation. Without biochemical screening for therapeutic non-adherence, the eligibility rate for renal denervation would have been 38.2%. Non-adherence to antihypertensive treatment and other forms of therapeutic pseudo-resistance are by far the most common reason of 'resistant hypertension' in patients referred for renal denervation. We suggest that inclusion of biochemical screening for non-adherence to antihypertensive treatment may be helpful in evaluation of patients with 'resistant hypertension' prior to consideration of renal denervation.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 50 条
  • [41] Adherence to antihypertensive medication in renal denervation trials: new studies, old problems?
    Lucas Lauder
    Felix Mahfoud
    Hypertension Research, 2023, 46 : 2543 - 2544
  • [42] The economic implications of non-adherence after renal transplantation
    Irina Cleemput
    Katrien Kesteloot
    Yves Vanrenterghem
    Sabina De Geest
    PharmacoEconomics, 2004, 22 : 1217 - 1234
  • [43] The economic implications of non-adherence after renal transplantation
    Cleemput, I
    Kesteloot, K
    Vanrenterghem, Y
    De Geest, S
    PHARMACOECONOMICS, 2004, 22 (18) : 1217 - 1234
  • [44] A typology of non-adherence in pediatric renal transplant recipients
    Shaw, RJ
    Palmer, L
    Blasey, C
    Sarwal, M
    PEDIATRIC TRANSPLANTATION, 2003, 7 (06) : 489 - 493
  • [45] Non-adherence and measures to improve adherence in the topical treatment of psoriasis
    Zschocke, I.
    Mrowietz, U.
    Karakasili, E.
    Reich, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 : 4 - 9
  • [46] Medication non-adherence and asthma treatment cost
    Bender, Bruce G.
    Rand, Cynthia
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (03) : 191 - 195
  • [47] Non-adherence factors in the treatment of psychotic disorders
    Tatarevic, M.
    Milovanovic, S.
    Latas, M.
    Nenadovic, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S550 - S550
  • [48] Non-Adherence to Anti-Hypertensive Treatment
    Shalini
    Goel, Manish Kumar
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2020, 32 (01) : 126 - 129
  • [49] Prevalence and reasons for non-adherence to hyperlipidemia treatment
    Kardas, Przemyslaw
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2013, 8 (05): : 539 - 547
  • [50] Educational multidisciplinary program in the non-adherence of the immunosuppressive treatment in pediatric renal transplant recipients
    Delucchi, A.
    Gutierrez, H.
    Meneses, M.
    Slater, C.
    Arrellano, P.
    Lopez, I.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1572 - 1572